Jul 14, 2021 7:30am EDT Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19
Jun 02, 2021 7:30am EDT Qualigen Therapeutics, Inc. to Present at the LD Micro Invitational XI Conference
May 19, 2021 7:30am EDT Qualigen Therapeutics, Inc. Appoints Tariq Arshad, MD, MBA as Chief Medical Officer
May 14, 2021 1:35pm EDT Qualigen Therapeutics, Inc. Reports First Quarter 2021 Financial Results and Provides Corporate Update
Mar 18, 2021 8:30am EDT Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
Mar 09, 2021 8:30am EST Qualigen Therapeutics, Inc. Promotes Shishir Sinha to Chief Operating Officer Position
Mar 08, 2021 8:30am EST Qualigen Therapeutics, Inc. to present at the Oppenheimer 31st Annual Healthcare Conference
Mar 01, 2021 8:30am EST Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL
Jan 26, 2021 9:00am EST Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China
